Government grants versus private capital in Canada is a decision most founders make too casually. A grant looks like free money, so it feels like the obvious first move. But the founders who raise well are not the ones who chase every program they qualify for. They are the ones who understand what each type of funding is actually for, and when non-dilutive money runs out of road.
2026 has made this decision more consequential than usual. Budget 2025 doubled the SR&ED enhanced-rate expenditure limit from $3 million to $6 million, CanExport SMEs tightened its eligibility bar to require at least 3 full-time employees and $300,000 in revenue for the 2026-27 cycle, and Ontario’s manufacturing sector gained a new Together Trade Fund aimed specifically at businesses exposed to U.S. tariffs. The programs are more generous in places and more selective in others, which means the sequencing question matters more than it did two years ago.
This guide continues our series on preparing a Canadian business for investment or incubation support and looks specifically at where government grants fit, where they stop being useful on their own, and how founders should think about combining them with private capital and operating support.
What government grants are actually good at
As of 2026, Canada runs roughly 400 active federal, provincial and municipal funding programs for small businesses, split across non-repayable grants, refundable tax credits, forgivable loans and government-backed financing. The three programs that come up most often for growth-stage founders are the National Research Council’s Industrial Research Assistance Program (NRC-IRAP), which can contribute up to $1 million in non-repayable funding toward eligible R&D salaries; the Scientific Research and Experimental Development (SR&ED) tax credit, which now returns up to 35% of eligible R&D spending for Canadian-controlled private corporations up to a $6 million expenditure limit; and the Canada Small Business Financing Program (CSBFP), a government-backed loan structure that can support up to $1.15 million for equipment, leasehold improvements and working capital.
These programs share a common strength: they do not require giving up equity. A founder who successfully stacks IRAP, SR&ED and a provincial R&D credit can, in some cases, cover a large share of a technical project’s cost without diluting ownership. That is genuinely valuable, and it is why grants deserve a real place in the funding conversation rather than being treated as a rounding error next to a venture round.
Where grants stop being enough on their own
Government funding has structural limits that show up regardless of how well a founder applies. IRAP will not reimburse costs incurred before a contribution agreement is signed, and the typical timeline from first contact to a signed agreement runs three to four months. SR&ED is retroactive, which helps cash flow after the fact but does nothing to fund the work while it is happening. CanExport’s 2026-27 eligibility tightening, requiring three FTEs and $300,000 in revenue, has pushed the program out of reach for many pre-revenue and early-stage companies that could have used it a year earlier.
None of this makes the programs less useful. It means they are built around a specific kind of eligible activity, usually R&D, export development or capital equipment, rather than around the general operating gap most early-stage Canadian businesses actually have: the gap between having a promising product and having a business that can consistently sell, deliver and collect on it. Grants rarely fund market validation, sales process design, pricing strategy or the operating discipline that determines whether growth capital gets used well once it arrives. That gap is where private capital and hands-on operating support tend to matter more than another government form.
The stacking rule founders miss
Most government programs can be combined, but not without limits. The general rule across federal programs is that total government assistance on a single project cannot exceed 75% to 100% of eligible costs, and the same dollar of spending cannot be claimed under two programs at once. A common structure looks like this: IRAP covers a portion of eligible R&D salary costs directly, SR&ED is then claimed on the remaining self-funded R&D spend, and a provincial R&D credit stacks on top where available. On a $500,000 project, that combination can realistically cover somewhere in the range of 80% to 90% of eligible cost, which is a meaningful result, but it is a result built entirely around R&D-eligible spending, not around working capital, hiring outside R&D, or the operating structure needed to actually commercialize what gets built.
| Funding source | Best suited for | What it typically will not cover |
|---|---|---|
| NRC-IRAP | Eligible R&D salaries, up to $1M non-repayable | Pre-agreement costs, non-R&D operating spend |
| SR&ED tax credit | Retroactive recovery of R&D spend, up to 35% | Cash flow during the project itself |
| CSBFP loan | Equipment, leasehold improvements, working capital | Repayable, so it adds debt service, not equity-free capital |
| Private capital / incubation | Market validation, go-to-market, operating structure, hiring | Nothing, but comes with equity, governance, or fee expectations |
How to sequence the two, in practice
A workable default order looks like this. Early on, when the business is proving that a real, repeatable problem exists, grants aimed at R&D and pre-revenue support (Futurpreneur for founders aged 18 to 39, IRAP if the work is genuinely technology-driven) can extend the runway without giving up ownership before there is much to value. Our earlier guide on market validation in Canada covers what “proving demand” should actually look like at this stage.
Once the business has real customers and a growth plan, the conversation usually shifts. This is where SR&ED becomes worth claiming annually as a matter of course, where CSBFP financing can fund the physical or working capital needs of scaling, and where the gap grants cannot fill, structured commercial support, resource matching, market strategy and operating discipline, becomes the binding constraint. That is the stage where a platform like TriApex Capital, working through consulting, incubation, direct investment or operating participation depending on the opportunity, tends to be more useful than another funding application. Our business model page explains how those different modes of involvement work.
Treat every program, government or private, as solving a specific problem rather than as generic fuel. A founder who can say precisely which constraint a dollar removes, whether it is R&D cost, working capital, market access, or execution capacity, is in a stronger position with any funder, public or private.
A practical starting checklist
- List every eligible cost category in the next 12 months separately: R&D salaries, capital equipment, export development, working capital, hiring outside R&D.
- Match each category to the program built for it, not the program that is easiest to apply to.
- Confirm stacking rules before applying to more than one program for the same cost, since exceeding the combined assistance cap can trigger repayment.
- Identify the operating gap grants will not touch: sales process, delivery capacity, pricing, team structure.
- Decide, honestly, whether that gap needs more cash or more hands-on operating support. They are not the same problem.
Government grants, tax credits and loans are, according to the Government of Canada’s Canada Small Business Financing Program resources, one part of a much wider financing landscape. They are worth pursuing deliberately. They are rarely the whole answer.
A worked example
Consider a Canadian-controlled manufacturing business in Ontario with a $500,000 project to develop a new production process. IRAP contributes $250,000 toward eligible R&D salary costs as a non-repayable contribution. The remaining $250,000 in self-funded R&D spend is claimed under SR&ED at the enhanced 35% rate, returning roughly $87,500. If the business is also exposed to U.S. tariffs on its finished goods, Ontario’s Together Trade Fund may cover a further share of retooling or market diversification costs. On paper, government support can reach somewhere close to 70% to 85% of the project’s direct cost.
What that combination does not touch is what happens after the process is built: hiring a plant manager who does not yet exist on the org chart, renegotiating supplier terms now that volume has changed, building a sales process that can sell the new capacity to buyers beyond the two customers who funded the original prototype. None of the three programs above will pay for that work, because none of them are designed to. That is not a flaw in the programs. It is a reminder that R&D funding and growth capital solve different problems, and a founder who only ever asks “what grant can I get next” will eventually hit a wall that no grant application closes.
What private capital actually costs, beyond the cheque
It is worth being direct about the trade-off, since grants and private capital are not simply “free money” versus “expensive money.” A grant costs time, documentation, and the discipline to track eligible spend correctly; miss the rules and you repay it. Private capital costs equity, governance input, and usually a faster pace of accountability, since an investor or incubation partner expects visible progress on a timeline, not just eventual results.
That is not a reason to avoid private capital. For a business past the R&D or pre-revenue stage, the involvement that comes with it, market positioning help, resource introductions, operating structure, management input, is often exactly what closes the gap grants cannot touch. The mistake is treating the two as substitutes rather than tools for different jobs. A founder who understands which constraint they are actually solving, cash, expertise, market access, or execution capacity, will choose the right tool instead of defaulting to whichever one is easiest to apply for this month.
Where TriApex fits
TriApex Capital is not a grant application service, and government programs are not part of what we provide directly. What we focus on is the funding gap that sits next to them: capital, business consulting, market planning and operating resources for Canadian businesses that have moved past the R&D or pre-revenue stage most grants are built for. If your business has outgrown what non-dilutive funding alone can solve, our investment focus page outlines the kind of opportunities we look for, and our contact page is the place to start a conversation.
This article is for general information only and does not constitute financial, tax or legal advice. Government program details, eligibility rules and funding caps change frequently; confirm current terms on official government sites before applying.